1. Home
  2. VSTM vs CCNE Comparison

VSTM vs CCNE Comparison

Compare VSTM & CCNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VSTM
  • CCNE
  • Stock Information
  • Founded
  • VSTM 2010
  • CCNE 1865
  • Country
  • VSTM United States
  • CCNE United States
  • Employees
  • VSTM N/A
  • CCNE N/A
  • Industry
  • VSTM Biotechnology: Pharmaceutical Preparations
  • CCNE Major Banks
  • Sector
  • VSTM Health Care
  • CCNE Finance
  • Exchange
  • VSTM Nasdaq
  • CCNE Nasdaq
  • Market Cap
  • VSTM 425.9M
  • CCNE 455.3M
  • IPO Year
  • VSTM 2012
  • CCNE N/A
  • Fundamental
  • Price
  • VSTM $6.14
  • CCNE $24.01
  • Analyst Decision
  • VSTM Strong Buy
  • CCNE Hold
  • Analyst Count
  • VSTM 9
  • CCNE 1
  • Target Price
  • VSTM $12.63
  • CCNE $29.00
  • AVG Volume (30 Days)
  • VSTM 2.5M
  • CCNE 120.8K
  • Earning Date
  • VSTM 08-07-2025
  • CCNE 07-22-2025
  • Dividend Yield
  • VSTM N/A
  • CCNE 3.05%
  • EPS Growth
  • VSTM N/A
  • CCNE 2.16
  • EPS
  • VSTM N/A
  • CCNE 2.38
  • Revenue
  • VSTM $10,000,000.00
  • CCNE $224,762,000.00
  • Revenue This Year
  • VSTM $81.24
  • CCNE $17.91
  • Revenue Next Year
  • VSTM $408.06
  • CCNE $27.71
  • P/E Ratio
  • VSTM N/A
  • CCNE $9.92
  • Revenue Growth
  • VSTM N/A
  • CCNE 4.79
  • 52 Week Low
  • VSTM $2.10
  • CCNE $19.32
  • 52 Week High
  • VSTM $9.10
  • CCNE $29.29
  • Technical
  • Relative Strength Index (RSI)
  • VSTM 66.83
  • CCNE 56.02
  • Support Level
  • VSTM $4.86
  • CCNE $23.54
  • Resistance Level
  • VSTM $5.62
  • CCNE $24.79
  • Average True Range (ATR)
  • VSTM 0.38
  • CCNE 0.61
  • MACD
  • VSTM 0.18
  • CCNE -0.04
  • Stochastic Oscillator
  • VSTM 91.23
  • CCNE 43.07

About VSTM Verastem Inc.

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

About CCNE CNB Financial Corporation

CNB Financial Corp is providing integrated financial solutions, which create value for both consumers and businesses. These solutions encompass deposit accounts, private banking, real estate, commercial, industrial, residential and consumer loans and lines of credit, credit cards, treasury services, online banking, mobile banking, merchant credit card processing, remote deposit and accounts receivable handling. It derives revenue through the operations as a full-service bank engaging in a full range of banking activities and services, including trust and wealth management services, for individual, business, governmental, and institutional customers. The company branch are located in Pennsylvania, Ohio, New York and Virginia.

Share on Social Networks: